ASX Announcement 28 October 2026 Quarterly Activities Report for the period ending 30 September 2026 Neurotech International Limited (ASX: NTI) (“Neurotech” or “the Company”), a clinical-stage biopharmaceutical company focused on paediatric neurological disorders, is pleased to present its...